Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Flexner

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|September 11, 2002
HLA B57 and abacavir hypersensitivityCharles Flexner
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|January 20, 2006
Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). New drugs, new targets: good news on the horizonCharles Flexner
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|September 21, 2002
Pharmacology and drug interactions: a progress reportAdriana Andrade, Charles Flexner
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|June 18, 2003
Progress in pharmacology and drug interactions from the 10th CROIAdriana Andrade, Charles Flexner
Current Opinion in HIV and AIDS|October 9, 2013
The antiretroviral drug pipeline: prospects and implications for future treatment researchCharles Flexner, Michael Saag
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|June 19, 2004
Genes, ethnicity, and efavirenz response: clinical pharmacology update from the 11th CROIAdriana Andrade, Charles Flexner
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|January 20, 2006
Pharmacology at the 12th CROI: generic antiretrovirals, drug interactions, and therapeutic drug monitoringAdriana Andrade, Charles Flexner
The Journal of Antimicrobial Chemotherapy|December 7, 2010
Emerging antiretroviral drug interactionsPaul A Pham, Charles Flexner
AIDS (London, England)|May 5, 2017
The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy developmentJanessa M Smith, Charles Flexner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 2020
Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?Matthew M Ippolito, Charles Flexner
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|September 11, 2002
HLA B57 and abacavir hypersensitivityCharles Flexner
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|January 20, 2006
Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). New drugs, new targets: good news on the horizonCharles Flexner
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|September 21, 2002
Pharmacology and drug interactions: a progress reportAdriana Andrade, Charles Flexner
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|June 18, 2003
Progress in pharmacology and drug interactions from the 10th CROIAdriana Andrade, Charles Flexner
Current Opinion in HIV and AIDS|October 9, 2013
The antiretroviral drug pipeline: prospects and implications for future treatment researchCharles Flexner, Michael Saag
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|June 19, 2004
Genes, ethnicity, and efavirenz response: clinical pharmacology update from the 11th CROIAdriana Andrade, Charles Flexner
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|January 20, 2006
Pharmacology at the 12th CROI: generic antiretrovirals, drug interactions, and therapeutic drug monitoringAdriana Andrade, Charles Flexner
The Journal of Antimicrobial Chemotherapy|December 7, 2010
Emerging antiretroviral drug interactionsPaul A Pham, Charles Flexner
AIDS (London, England)|May 5, 2017
The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy developmentJanessa M Smith, Charles Flexner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 2020
Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?Matthew M Ippolito, Charles Flexner
Pageof 14